Option Care Health (OPCH) Financials

$31.84 +0.29 (+0.92%)

As of 04/14/2025 04:00 PM Eastern

Annual Income Statements for Option Care Health

This table shows Option Care Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-310	-52	3.88	-6.12	-76	-8.08	140	172	261	208
Consolidated Net Income / (Loss)	-300	-43	3.88	-6.12	-76	-8.08	140	151	267	212
Net Income / (Loss) Continuing Operations	-305	-36	3.88	-6.12	-76	-8.08	140	151	267	212
Total Pre-Tax Income	-326	-34	-15	-8.77	-78	-5.24	116	206	359	284
Total Operating Income	-247	-11	27	38	-0.32	111	191	240	315	322
Total Gross Profit	260	262	446	422	513	682	780	867	981	1,013
Total Revenue	982	936	1,828	1,940	2,310	3,033	3,439	3,945	4,302	4,998
Operating Revenue	982	936	1,828	1,940	2,310	3,033	3,439	3,945	4,302	4,998
Total Cost of Revenue	722	700	1,382	1,518	1,797	2,350	2,659	3,078	3,321	3,985
Operating Cost of Revenue	722	674	1,382	1,518	1,797	2,350	2,659	3,078	3,321	3,985
Total Operating Expenses	507	246	419	384	513	572	589	627	667	691
Selling, General & Admin Expense	208	209	338	346	460	500	526	566	607	630
Depreciation Expense	23	22	35	38	54	71	63	61	59	61
Total Other Income / (Expense), net	-79	-23	-42	-47	-78	-116	-74	-34	44	-38
Interest Expense	79	0.00	-	46	74	108	67	54	51	49
Interest & Investment Income	-	-38	2.19	1.02	2.84	3.31	6.03	5.13	5.53	5.96
Other Income / (Expense), net	0.00	14	-44	-2.23	-6.99	-12	-13	14	90	4.83
Income Tax Expense	-22	2.02	-19	-2.65	-2.27	2.83	-23	55	92	72
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	-	-22	6.18	3.93
Basic Earnings per Share	($4.51)	($0.55)	$0.03	($0.04)	($0.49)	($0.04)	$0.78	$0.83	$1.49	$1.23
Weighted Average Basic Shares Outstanding	68.71M	93.74M	142.61M	142.61M	156.28M	180.97M	179.86M	181.11M	178.97M	171.57M
Diluted Earnings per Share	($4.51)	($0.55)	$0.03	($0.04)	($0.49)	($0.04)	$0.77	$0.83	$1.48	$1.23
Weighted Average Diluted Shares Outstanding	68.71M	93.74M	142.61M	142.61M	156.28M	180.97M	181.21M	182.08M	180.38M	172.85M
Weighted Average Basic & Diluted Shares Outstanding	68.71M	93.74M	142.61M	142.61M	156.28M	179.81M	179.94M	181.96M	173.50M	165.32M

This table shows Option Care Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	48	55	39	114	56	51	45	53	48	62
Consolidated Net Income / (Loss)	39	48	39	114	56	57	45	53	54	60
Net Income / (Loss) Continuing Operations	39	48	39	114	56	57	45	53	54	60
Total Pre-Tax Income	52	65	54	156	70	79	57	72	74	81
Total Operating Income	61	68	67	82	81	85	69	81	85	87
Total Gross Profit	218	231	229	251	254	247	239	249	257	268
Total Revenue	1,021	1,027	1,016	1,069	1,093	1,124	1,146	1,227	1,279	1,346
Operating Revenue	1,021	1,027	1,016	1,069	1,093	1,124	1,146	1,227	1,279	1,346
Total Cost of Revenue	803	796	787	818	839	877	908	978	1,022	1,078
Operating Cost of Revenue	803	796	787	818	839	877	908	978	1,022	1,078
Total Operating Expenses	157	163	162	168	173	163	169	169	172	181
Selling, General & Admin Expense	142	148	148	154	158	148	155	154	157	165
Depreciation Expense	15	15	15	15	15	15	15	15	15	17
Total Other Income / (Expense), net	-8.64	-3.41	-12	73	-11	-5.63	-12	-8.63	-12	-5.99
Interest Expense	14	15	14	13	12	12	13	13	12	11
Interest & Investment Income	1.47	1.06	1.44	1.40	1.27	1.42	1.13	1.41	1.39	2.04
Other Income / (Expense), net	3.89	10	0.00	85	-0.45	5.38	0.00	2.56	-0.58	2.85
Income Tax Expense	13	17	15	41	14	22	12	19	20	21
Basic Earnings per Share	$0.21	$0.26	$0.22	$0.64	$0.31	$0.32	$0.26	$0.31	$0.32	$0.34
Weighted Average Basic Shares Outstanding	181.88M	181.11M	181.26M	179.81M	178.83M	178.97M	173.93M	172.93M	170.64M	171.57M
Diluted Earnings per Share	$0.21	$0.26	$0.21	$0.63	$0.31	$0.33	$0.26	$0.30	$0.31	$0.36
Weighted Average Diluted Shares Outstanding	183.02M	182.08M	182.74M	181.24M	180.53M	180.38M	175.62M	174.09M	171.94M	172.85M
Weighted Average Basic & Diluted Shares Outstanding	181.90M	181.96M	179.76M	179.88M	177.13M	173.50M	173.82M	171.02M	170.18M	165.32M

This table details how cash moves in and out of Option Care Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	15	-6.01	8.25	-17	31	32	20	175	50	69
Net Cash From Operating Activities	-64	-43	38	24	39	127	209	268	371	323
Net Cash From Continuing Operating Activities	-63	-36	38	24	39	127	209	268	371	323
Net Income / (Loss) Continuing Operations	-305	-36	3.88	-6.12	-76	-8.08	140	151	267	212
Consolidated Net Income / (Loss)	-300	-43	3.88	-6.12	-76	-8.08	140	151	267	212
Depreciation Expense	23	22	38	41	58	78	69	65	62	63
Amortization Expense	3.44	4.04	3.00	3.11	4.54	5.52	5.00	4.30	4.45	4.63
Non-Cash Adjustments To Reconcile Net Income	255	-17	1.46	7.79	25	27	17	6.45	47	34
Changes in Operating Assets and Liabilities, net	-39	-8.53	-8.53	-21	28	25	-22	41	-9.92	9.82
Net Cash From Investing Activities	13	-73	-24	-37	-728	-26	-112	-108	-57	-36
Net Cash From Continuing Investing Activities	-12	-73	-24	-37	-728	-26	-112	-108	-57	-36
Purchase of Property, Plant & Equipment	-12	-9.87	-25	-26	-28	-27	-26	-35	-42	-36
Acquisitions	0.00	-68	0.00	-11	-700	0.00	-86	-87	-12	0.00
Sale of Property, Plant & Equipment	0.00	4.18	0.48	0.00	0.01	0.00	0.00	15	3.74	0.00
Other Investing Activities, net	0.00	-	0.00	0.00	0.63	0.54	0.00	0.00	-5.89	-0.86
Net Cash From Financing Activities	67	110	-5.15	-4.15	719	-69	-77	15	-265	-218
Net Cash From Continuing Financing Activities	67	110	-5.15	-4.15	719	-69	-77	15	-265	-218
Repayment of Debt	-197	-78	-4.15	-5.15	-261	-187	-932	-6.00	-12	-3.06
Repurchase of Common Equity	-	-	-	-	-	-	0.00	0.00	-250	-253
Issuance of Debt	204	104	0.00	1.00	981	0.00	855	0.00	0.00	50
Other Financing Activities, net	-	-0.20	-1.00	0.00	-1.19	-0.90	-0.03	21	-3.12	-12
Cash Interest Paid	34	35	43	47	51	98	61	50	70	72
Cash Income Taxes Paid	0.11	-0.37	1.19	1.60	2.41	2.88	5.71	13	75	65

This table details how cash moves in and out of Option Care Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	51	39	3.59	143	-55	-43	-124	157	106	-70
Net Cash From Operating Activities	87	43	90	170	61	51	-69	196	160	36
Net Cash From Continuing Operating Activities	87	43	90	170	61	51	-69	196	160	36
Net Income / (Loss) Continuing Operations	39	48	39	114	56	57	45	53	54	60
Consolidated Net Income / (Loss)	39	48	39	114	56	57	45	53	54	60
Depreciation Expense	16	16	15	16	16	16	15	15	15	17
Amortization Expense	1.09	1.10	1.08	1.10	1.13	1.13	1.13	1.17	1.16	1.16
Non-Cash Adjustments To Reconcile Net Income	4.16	-3.65	7.32	7.60	9.47	23	10	6.61	9.53	7.24
Changes in Operating Assets and Liabilities, net	27	-17	27	31	-21	-46	-140	119	81	-50
Net Cash From Investing Activities	-34	-3.63	-5.76	-21	-14	-16	-5.82	-9.78	-9.67	-11
Net Cash From Continuing Investing Activities	-34	-3.63	-5.76	-21	-14	-16	-5.82	-9.78	-9.67	-11
Purchase of Property, Plant & Equipment	-7.06	-18	-5.76	-7.79	-8.43	-20	-5.82	-9.78	-9.67	-10
Other Investing Activities, net	-	-	-	-	-	-	-	-	-	-0.86
Net Cash From Financing Activities	-1.24	-1.11	-80	-5.50	-101	-78	-50	-29	-45	-95
Net Cash From Continuing Financing Activities	-1.24	-1.11	-80	-5.50	-101	-78	-50	-29	-45	-95
Repayment of Debt	-1.50	-1.50	-3.50	-5.25	-1.50	-1.50	-1.50	-0.41	0.48	-1.63
Repurchase of Common Equity	-	-	-75	-	-100	-75	-40	-78	-42	-93
Other Financing Activities, net	0.26	0.39	-1.90	-0.25	0.21	-1.18	-8.18	-0.00	-3.05	-1.15
Cash Interest Paid	7.79	21	11	23	12	23	12	24	13	23
Cash Income Taxes Paid	1.72	6.75	0.00	22	32	22	0.00	32	13	19

This table presents Option Care Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	531	605	603	1,428	2,590	2,647	2,791	3,113	3,217	3,422
Total Current Assets	184	173	187	467	559	657	710	994	1,094	1,323
Cash & Equivalents	16	9.57	39	36	67	99	119	294	344	413
Accounts Receivable	97	109	86	310	324	328	338	378	378	410
Inventories, net	43	36	38	83	116	159	183	224	274	388
Prepaid Expenses	28	19	19	38	51	71	69	98	99	112
Plant, Property, & Equipment, net	32	33	27	93	133	121	112	108	121	127
Total Noncurrent Assets	315	399	390	868	1,898	1,869	1,603	2,010	2,002	1,972
Goodwill	309	366	367	632	1,426	1,429	1,478	1,533	1,540	1,540
Intangible Assets	5.13	31	19	220	386	23	-	22	20	301
Other Noncurrent Operating Assets	1.16	1.99	2.12	15	86	417	99	454	442	130
Total Liabilities & Shareholders' Equity	531	605	603	1,428	2,590	2,647	2,791	3,113	3,217	3,422
Total Liabilities	549	567	606	825	1,683	1,632	1,615	1,727	1,795	2,018
Total Current Liabilities	153	130	105	240	330	434	460	565	618	780
Short-Term Debt	24	19	1.72	4.15	9.25	9.25	6.00	6.00	6.00	6.51
Accounts Payable	65	64	66	188	221	283	279	379	427	611
Accrued Expenses	53	37	26	23	34	64	72	84	75	78
Current Employee Benefit Liabilities	-	-	-	25	46	59	84	77	93	63
Other Current Liabilities	3.49	3.68	4.62	0.00	20	19	19	19	18	22
Total Noncurrent Liabilities	396	436	501	585	1,353	1,198	1,155	1,161	1,177	1,237
Long-Term Debt	394	433	479	535	1,277	1,115	1,060	1,058	1,057	1,105
Noncurrent Deferred & Payable Income Tax Liabilities	0.24	2.28	-	33	2.14	3.34	0.00	22	35	48
Other Noncurrent Operating Liabilities	1.86	0.76	22	17	73	79	95	81	85	85
Total Equity & Noncontrolling Interests	-81	-34	-85	603	907	1,016	1,176	1,386	1,422	1,404
Total Preferred & Common Equity	-81	-34	-85	603	907	1,016	1,176	1,386	1,422	1,404
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-81	-34	-85	603	907	1,016	1,176	1,386	1,422	1,404
Common Stock	532	612	625	620	1,008	1,129	1,139	1,177	1,204	1,231
Retained Earnings	-602	-645	-710	-16	-92	-100	40	190	458	669
Treasury Stock	-11	0.00	-0.02	0.00	-2.40	-2.40	-2.40	-2.40	-255	-508
Accumulated Other Comprehensive Income / (Loss)	-	-	-	0.84	-7.20	-11	-0.45	21	15	11

This table presents Option Care Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	3,073	3,130	3,321	3,244	3,250	3,349	3,428
Total Current Assets	952	1,030	1,198	1,116	1,130	1,227	1,321
Cash & Equivalents	255	298	441	386	220	377	483
Accounts Receivable	364	395	397	383	574	468	429
Inventories, net	236	250	263	251	242	281	311
Prepaid Expenses	96	87	98	95	95	101	99
Plant, Property, & Equipment, net	96	106	107	108	121	124	126
Total Noncurrent Assets	2,025	1,640	2,016	2,019	1,999	1,997	1,980
Goodwill	1,533	1,534	1,541	1,540	1,540	1,540	1,540
Intangible Assets	23	-	22	344	327	318	310
Other Noncurrent Operating Assets	469	106	454	135	132	139	131
Total Liabilities & Shareholders' Equity	3,073	3,130	3,321	3,244	3,250	3,349	3,428
Total Liabilities	1,736	1,780	1,846	1,804	1,820	1,937	2,001
Total Current Liabilities	587	619	668	624	637	695	763
Short-Term Debt	6.00	6.00	6.00	6.00	6.00	6.51	6.51
Accounts Payable	410	449	468	430	486	536	592
Accrued Expenses	94	96	103	89	83	69	82
Current Employee Benefit Liabilities	58	49	73	81	43	62	61
Other Current Liabilities	19	19	19	18	19	22	22
Total Noncurrent Liabilities	1,149	1,162	1,177	1,179	1,183	1,242	1,238
Long-Term Debt	1,059	1,058	1,057	1,057	1,056	1,106	1,105
Noncurrent Deferred & Payable Income Tax Liabilities	11	31	35	34	38	45	45
Other Noncurrent Operating Liabilities	80	73	84	89	89	92	88
Total Equity & Noncontrolling Interests	1,337	1,350	1,475	1,440	1,429	1,411	1,426
Total Preferred & Common Equity	1,337	1,350	1,475	1,440	1,429	1,411	1,426
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,337	1,350	1,475	1,440	1,429	1,411	1,426
Common Stock	1,172	1,181	1,188	1,198	1,206	1,215	1,224
Retained Earnings	143	230	344	400	502	555	609
Treasury Stock	-2.40	-78	-78	-179	-295	-374	-417
Accumulated Other Comprehensive Income / (Loss)	25	18	21	21	17	16	9.50

This table displays calculated financial ratios and metrics derived from Option Care Health's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.46%	-4.75%	95.39%	6.11%	19.11%	31.26%	13.39%	14.72%	9.07%	16.17%
EBITDA Growth	-212.06%	113.36%	-18.03%	231.88%	-31.29%	231.43%	37.59%	29.02%	45.32%	-16.20%
EBIT Growth	-152.50%	101.38%	-594.67%	313.32%	-120.29%	1,457.24%	78.87%	43.38%	58.96%	-19.23%
NOPAT Growth	-152.50%	95.55%	348.24%	40.29%	-100.83%	34,819.44%	195.61%	-23.30%	33.25%	2.63%
Net Income Growth	-103.52%	85.75%	109.07%	-257.68%	-1,141.54%	89.36%	1,832.27%	7.62%	77.40%	-20.69%
EPS Growth	-109.77%	87.80%	109.07%	-257.68%	-1,141.54%	91.84%	2,025.00%	7.79%	78.31%	-16.89%
Operating Cash Flow Growth	-104.45%	33.77%	189.02%	-35.50%	61.56%	222.78%	63.72%	28.28%	38.78%	-12.90%
Free Cash Flow Firm Growth	74.01%	-283.21%	163.99%	-1,063.04%	-59.78%	115.97%	215.15%	-143.61%	211.55%	11.27%
Invested Capital Growth	-36.95%	24.51%	-9.69%	151.20%	92.28%	-4.02%	-13.94%	22.76%	-0.73%	-1.76%
Revenue Q/Q Growth	4.13%	-0.39%	108.98%	-4.53%	-14.15%	2.85%	3.69%	2.60%	2.31%	4.65%
EBITDA Q/Q Growth	28.10%	-47.31%	31.20%	-14.11%	-17.99%	16.60%	7.08%	6.01%	2.51%	0.43%
EBIT Q/Q Growth	26.03%	-90.00%	4.29%	-20.89%	-153.34%	37.68%	11.75%	7.95%	2.90%	-0.02%
NOPAT Q/Q Growth	26.03%	-132.19%	254.55%	-70.47%	-102.51%	37.78%	40.45%	-20.50%	5.13%	1.44%
Net Income Q/Q Growth	12.98%	10.72%	105.11%	-115.38%	-90.47%	80.65%	70.05%	-15.65%	3.75%	1.42%
EPS Q/Q Growth	12.26%	24.66%	105.11%	-115.38%	-90.47%	96.75%	-48.32%	-21.70%	4.96%	2.50%
Operating Cash Flow Q/Q Growth	3.12%	-17.70%	382.09%	-58.94%	37.04%	2.22%	23.47%	-7.55%	2.07%	-4.39%
Free Cash Flow Firm Q/Q Growth	23.56%	-111.61%	183.35%	-776.33%	39.42%	-1.83%	216.10%	-322.14%	-1.11%	-6.94%
Invested Capital Q/Q Growth	-4.08%	1.34%	-1.13%	150.46%	-0.42%	0.75%	-13.32%	0.45%	1.13%	2.34%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	26.47%	28.01%	24.40%	21.77%	22.20%	22.50%	22.67%	21.98%	22.81%	20.27%
EBITDA Margin	-22.47%	3.15%	1.32%	4.13%	2.39%	6.02%	7.31%	8.22%	10.95%	7.90%
Operating Margin	-25.14%	-1.17%	1.49%	1.97%	-0.01%	3.65%	5.55%	6.09%	7.31%	6.44%
EBIT Margin	-25.14%	0.37%	-0.92%	1.86%	-0.32%	3.27%	5.16%	6.45%	9.40%	6.54%
Profit (Net Income) Margin	-30.56%	-4.57%	0.21%	-0.32%	-3.29%	-0.27%	4.07%	3.82%	6.21%	4.24%
Tax Burden Percent	91.96%	125.20%	-26.37%	69.74%	97.09%	154.03%	120.09%	73.17%	74.45%	74.69%
Interest Burden Percent	132.14%	-1,000.21%	87.06%	-24.33%	1,069.69%	-5.28%	65.64%	80.87%	88.70%	86.82%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-20.09%	26.83%	25.55%	25.31%
Return on Invested Capital (ROIC)	-34.15%	-1.75%	4.12%	3.47%	-0.01%	3.72%	12.07%	8.99%	10.90%	11.33%
ROIC Less NNEP Spread (ROIC-NNEP)	-65.43%	-9.92%	0.70%	-3.49%	-8.80%	-3.91%	0.95%	5.25%	15.32%	7.30%
Return on Net Nonoperating Assets (RNNOA)	-267.72%	-417.08%	17.60%	-5.50%	-10.04%	-4.56%	0.70%	2.77%	8.12%	3.66%
Return on Equity (ROE)	-301.87%	-418.83%	21.72%	-2.04%	-10.06%	-0.84%	12.77%	11.75%	19.03%	14.99%
Cash Return on Invested Capital (CROIC)	11.18%	-23.59%	14.30%	-82.64%	-63.16%	7.82%	27.05%	-11.45%	11.63%	13.10%
Operating Return on Assets (OROA)	-36.44%	0.60%	-2.80%	3.55%	-0.36%	3.79%	6.53%	8.62%	12.78%	9.84%
Return on Assets (ROA)	-44.29%	-7.53%	0.64%	-0.60%	-3.78%	-0.31%	5.14%	5.10%	8.44%	6.38%
Return on Common Equity (ROCE)	-206.35%	2,348.37%	-72.00%	-1.76%	-10.06%	-0.84%	12.77%	11.75%	19.03%	14.99%
Return on Equity Simple (ROE_SIMPLE)	371.09%	127.20%	-4.58%	-1.01%	-8.37%	-0.80%	11.90%	10.86%	18.79%	15.08%
Net Operating Profit after Tax (NOPAT)	-173	-7.69	19	27	-0.22	78	229	176	234	240
NOPAT Margin	-17.60%	-0.82%	1.04%	1.38%	-0.01%	2.56%	6.66%	4.46%	5.44%	4.81%
Net Nonoperating Expense Percent (NNEP)	31.28%	8.17%	3.41%	6.96%	8.79%	7.63%	11.12%	3.73%	-4.42%	4.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	7.17%	9.43%	9.56%
Cost of Revenue to Revenue	73.53%	74.83%	75.60%	78.23%	77.80%	77.50%	77.33%	78.02%	77.19%	79.73%
SG&A Expenses to Revenue	21.16%	22.29%	18.51%	17.83%	19.89%	16.49%	15.29%	14.35%	14.12%	12.61%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	51.61%	26.34%	22.91%	19.79%	22.22%	18.85%	17.12%	15.89%	15.49%	13.83%
Earnings before Interest and Taxes (EBIT)	-247	3.42	-17	36	-7.31	99	177	254	404	327
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-221	29	24	80	55	183	251	324	471	395
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.76	2.90	2.88	4.35	3.95	4.20	2.81
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.12	0.13	0.20	0.24	1.14	0.96	1.49	1.39	1.39	0.79
Price to Earnings (P/E)	0.00	0.00	95.69	0.00	0.00	0.00	36.57	31.79	22.87	18.99
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	1.05%	0.00%	0.00%	0.00%	2.73%	3.15%	4.37%	5.27%
Enterprise Value to Invested Capital (EV/IC)	1.50	1.31	2.02	0.87	1.81	1.93	3.45	2.90	3.12	2.21
Enterprise Value to Revenue (EV/Rev)	0.60	0.68	0.49	0.49	1.67	1.30	1.76	1.58	1.55	0.93
Enterprise Value to EBITDA (EV/EBITDA)	0.00	21.60	36.80	11.97	69.91	21.61	24.13	19.26	14.19	11.77
Enterprise Value to EBIT (EV/EBIT)	0.00	186.46	0.00	26.64	0.00	39.77	34.16	24.54	16.53	14.23
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	46.57	35.84	0.00	50.90	26.45	35.52	28.55	19.33
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	23.48	39.30	97.61	30.98	29.07	23.34	18.01	14.37
Enterprise Value to Free Cash Flow (EV/FCFF)	10.35	0.00	13.41	0.00	0.00	24.21	11.80	0.00	26.76	16.71
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-23.28	11.77	-179.79	0.89	1.42	1.11	0.91	0.77	0.75	0.79
Long-Term Debt to Equity	-21.92	11.29	-179.15	0.89	1.41	1.10	0.90	0.76	0.74	0.79
Financial Leverage	4.09	42.04	24.98	1.58	1.14	1.17	0.73	0.53	0.53	0.50
Leverage Ratio	6.82	55.61	33.83	3.38	2.66	2.72	2.48	2.30	2.25	2.35
Compound Leverage Factor	9.01	-556.22	29.45	-0.82	28.47	-0.14	1.63	1.86	2.00	2.04
Debt to Total Capital	104.49%	92.17%	100.56%	47.22%	58.66%	52.54%	47.55%	43.43%	42.77%	44.17%
Short-Term Debt to Total Capital	6.09%	3.78%	0.36%	0.36%	0.42%	0.43%	0.27%	0.24%	0.24%	0.26%
Long-Term Debt to Total Capital	98.40%	88.39%	100.20%	46.86%	58.23%	52.11%	47.28%	43.19%	42.53%	43.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	15.72%	14.68%	17.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-20.21%	-6.86%	-17.73%	52.78%	41.34%	47.46%	52.45%	56.57%	57.23%	55.83%
Debt to EBITDA	-1.89	15.33	19.89	6.73	23.35	6.16	4.24	3.28	2.26	2.81
Net Debt to EBITDA	-1.82	15.00	18.05	6.27	22.13	5.61	3.77	2.38	1.53	1.77
Long-Term Debt to EBITDA	-1.78	14.70	19.82	6.67	23.18	6.11	4.22	3.26	2.24	2.80
Debt to NOPAT	-2.42	-58.75	25.17	20.13	-5,761.29	14.50	4.65	6.05	4.54	4.62
Net Debt to NOPAT	-2.33	-57.51	22.84	18.78	-5,460.99	13.22	4.13	4.38	3.07	2.91
Long-Term Debt to NOPAT	-2.28	-56.34	25.08	19.98	-5,719.87	14.38	4.62	6.02	4.51	4.60
Altman Z-Score	-1.07	0.29	1.82	1.95	1.88	2.39	3.47	3.69	4.12	3.41
Noncontrolling Interest Sharing Ratio	31.64%	660.69%	431.50%	13.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.20	1.33	1.77	1.95	1.69	1.51	1.55	1.76	1.77	1.70
Quick Ratio	0.74	0.91	1.19	1.44	1.19	0.99	1.00	1.19	1.17	1.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	57	-104	66	-639	-1,021	163	514	-224	250	278
Operating Cash Flow to CapEx	-532.76%	-747.25%	154.75%	92.97%	139.55%	474.02%	813.71%	1,293.25%	973.94%	908.25%
Free Cash Flow to Firm to Interest Expense	0.71	0.00	0.00	-13.94	-13.84	1.51	7.67	-4.16	4.88	5.67
Operating Cash Flow to Interest Expense	-0.81	0.00	0.00	0.53	0.54	1.18	3.11	4.97	7.25	6.60
Operating Cash Flow Less CapEx to Interest Expense	-0.96	0.00	0.00	-0.04	0.15	0.93	2.73	4.59	6.50	5.87
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.45	1.65	3.03	1.91	1.15	1.16	1.26	1.34	1.36	1.51
Accounts Receivable Turnover	8.58	9.06	18.79	9.80	7.28	9.29	10.32	11.02	11.39	12.70
Inventory Turnover	18.01	17.69	37.25	25.00	18.04	17.13	15.56	15.11	13.33	12.04
Fixed Asset Turnover	28.02	28.96	61.29	32.30	20.42	23.85	29.56	35.88	37.58	40.31
Accounts Payable Turnover	9.36	10.81	21.20	11.96	8.79	9.33	9.46	9.35	8.25	7.68
Days Sales Outstanding (DSO)	42.55	40.27	19.43	37.23	50.13	39.28	35.38	33.12	32.03	28.75
Days Inventory Outstanding (DIO)	20.26	20.63	9.80	14.60	20.23	21.31	23.45	24.16	27.38	30.32
Days Payable Outstanding (DPO)	38.98	33.76	17.22	30.53	41.52	39.13	38.58	39.02	44.25	47.50
Cash Conversion Cycle (CCC)	23.83	27.14	12.01	21.30	28.83	21.46	20.25	18.25	15.17	11.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	391	487	440	1,106	2,126	2,041	1,756	2,156	2,140	2,103
Invested Capital Turnover	1.94	2.13	3.94	2.51	1.43	1.46	1.81	2.02	2.00	2.36
Increase / (Decrease) in Invested Capital	-229	96	-47	666	1,020	-85	-284	400	-16	-38
Enterprise Value (EV)	586	637	889	960	3,852	3,946	6,062	6,243	6,686	4,647
Market Capitalization	120	122	371	457	2,633	2,921	5,116	5,473	5,968	3,948
Book Value per Share	($1.18)	($0.29)	($0.66)	$4.71	$1.28	$5.44	$6.54	$7.62	$8.03	$8.25
Tangible Book Value per Share	($5.74)	($3.66)	($3.69)	($1.95)	($1.28)	($2.34)	($1.68)	($0.93)	($0.78)	($2.57)
Total Capital	400	490	478	1,142	2,193	2,140	2,242	2,450	2,484	2,515
Total Debt	418	452	481	539	1,286	1,124	1,066	1,064	1,063	1,111
Total Long-Term Debt	394	433	479	535	1,277	1,115	1,060	1,058	1,057	1,105
Net Debt	403	442	436	503	1,219	1,025	946	770	719	699
Capital Expenditures (CapEx)	12	5.69	24	26	28	27	26	21	38	36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	40	52	39	195	171	133	137	141	138	136
Debt-free Net Working Capital (DFNWC)	55	62	83	232	238	232	257	435	482	549
Net Working Capital (NWC)	31	43	81	227	229	223	251	429	476	542
Net Nonoperating Expense (NNE)	127	35	15	33	76	86	89	25	-33	29
Net Nonoperating Obligations (NNO)	409	449	443	503	1,219	1,025	580	770	719	699
Total Depreciation and Amortization (D&A)	26	26	41	44	62	83	74	70	67	68
Debt-free, Cash-free Net Working Capital to Revenue	4.04%	5.57%	2.12%	10.06%	7.39%	4.38%	3.99%	3.57%	3.21%	2.73%
Debt-free Net Working Capital to Revenue	5.63%	6.59%	4.55%	11.94%	10.30%	7.66%	7.46%	11.03%	11.20%	10.98%
Net Working Capital to Revenue	3.15%	4.62%	4.46%	11.72%	9.90%	7.35%	7.29%	10.88%	11.06%	10.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($18.04)	($2.16)	($2.40)	($1.96)	($0.49)	($0.04)	$0.78	$0.83	$1.49	$1.23
Adjusted Weighted Average Basic Shares Outstanding	17.19M	30.25M	31.92M	32.04M	176.70M	179.81M	179.86M	181.11M	178.97M	171.57M
Adjusted Diluted Earnings per Share	($18.04)	($2.16)	($2.40)	($1.96)	($0.49)	($0.04)	$0.77	$0.83	$1.48	$1.23
Adjusted Weighted Average Diluted Shares Outstanding	17.19M	30.25M	31.92M	32.04M	176.70M	179.81M	181.21M	182.08M	180.38M	172.85M
Adjusted Basic & Diluted Earnings per Share	($18.04)	($2.16)	($2.40)	($1.96)	($0.49)	($0.04)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.18M	23.44M	30.95M	31.99M	156.28M	180.97M	179.94M	181.96M	173.50M	165.32M
Normalized Net Operating Profit after Tax (NOPAT)	21	3.41	19	27	-0.22	78	134	176	234	240
Normalized NOPAT Margin	2.09%	0.36%	1.04%	1.38%	-0.01%	2.56%	3.88%	4.46%	5.44%	4.81%
Pre Tax Income Margin	-33.23%	-3.65%	-0.80%	-0.45%	-3.38%	-0.17%	3.39%	5.22%	8.34%	5.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.11	0.00	0.00	0.79	-0.10	0.92	2.65	4.73	7.89	6.66
NOPAT to Interest Expense	-2.18	0.00	0.00	0.58	0.00	0.72	3.42	3.27	4.57	4.90
EBIT Less CapEx to Interest Expense	-3.26	0.00	0.00	0.21	-0.48	0.67	2.27	4.34	7.15	5.94
NOPAT Less CapEx to Interest Expense	-2.33	0.00	0.00	0.01	-0.39	0.47	3.04	2.88	3.83	4.18
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	93.70%	119.31%

This table displays calculated financial ratios and metrics derived from Option Care Health's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.46%	10.79%	10.93%	9.00%	7.06%	9.46%	12.82%	14.79%	16.97%	19.75%
EBITDA Growth	15.23%	23.88%	19.72%	137.66%	18.47%	12.08%	3.06%	-45.70%	3.65%	1.56%
EBIT Growth	22.16%	31.32%	27.52%	183.19%	24.75%	14.54%	3.61%	-50.25%	4.85%	-0.05%
NOPAT Growth	-6.96%	-48.76%	25.68%	44.02%	43.85%	22.44%	12.70%	-1.98%	-4.31%	5.42%
Net Income Growth	9.43%	-37.02%	29.51%	237.18%	45.02%	20.30%	14.24%	-53.64%	-4.34%	5.17%
EPS Growth	5.00%	-38.10%	23.53%	231.58%	47.62%	26.92%	23.81%	-52.38%	0.00%	9.09%
Operating Cash Flow Growth	70.11%	-33.46%	174.63%	62.59%	-29.95%	17.29%	-176.64%	15.41%	162.79%	-29.13%
Free Cash Flow Firm Growth	-256.35%	-191.53%	796.25%	248.09%	226.65%	121.99%	-206.49%	-90.49%	30.66%	32.92%
Invested Capital Growth	5.93%	22.76%	-17.79%	-2.25%	-1.39%	-0.73%	29.05%	2.34%	-2.92%	-1.76%
Revenue Q/Q Growth	4.09%	0.62%	-1.11%	5.24%	2.24%	2.87%	1.93%	7.08%	4.19%	5.31%
EBITDA Q/Q Growth	6.14%	16.01%	-13.00%	121.84%	-47.09%	9.76%	-20.01%	16.90%	0.98%	7.56%
EBIT Q/Q Growth	9.36%	21.54%	-15.15%	151.11%	-51.82%	11.58%	-23.24%	20.58%	1.52%	6.36%
NOPAT Q/Q Growth	7.57%	10.54%	-3.72%	25.80%	7.44%	-5.92%	-11.38%	9.42%	4.89%	3.65%
Net Income Q/Q Growth	14.42%	22.42%	-17.51%	191.78%	-50.79%	1.55%	-21.66%	18.42%	1.53%	11.66%
EPS Q/Q Growth	10.53%	23.81%	-19.23%	200.00%	-50.79%	6.45%	-21.21%	15.38%	3.33%	16.13%
Operating Cash Flow Q/Q Growth	-16.43%	-50.13%	106.54%	88.89%	-64.00%	-16.50%	-234.95%	384.45%	-18.02%	-77.48%
Free Cash Flow Firm Q/Q Growth	-1.93%	-366.39%	222.73%	-74.62%	-12.83%	-19.02%	-694.35%	102.27%	1,097.54%	-17.62%
Invested Capital Q/Q Growth	0.02%	0.45%	-18.35%	19.14%	0.91%	1.13%	6.14%	-5.51%	-4.28%	2.34%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.35%	22.50%	22.54%	23.46%	23.26%	21.98%	20.81%	20.32%	20.08%	19.93%
EBITDA Margin	8.05%	9.28%	8.16%	17.21%	8.91%	9.50%	7.46%	8.14%	7.89%	8.06%
Operating Margin	5.95%	6.64%	6.56%	7.70%	7.42%	7.52%	6.02%	6.57%	6.66%	6.46%
EBIT Margin	6.33%	7.64%	6.56%	15.65%	7.37%	8.00%	6.02%	6.78%	6.61%	6.68%
Profit (Net Income) Margin	3.80%	4.63%	3.86%	10.70%	5.15%	5.09%	3.91%	4.32%	4.21%	4.47%
Tax Burden Percent	74.54%	73.37%	72.30%	73.57%	80.33%	72.44%	78.64%	73.63%	73.22%	74.19%
Interest Burden Percent	80.61%	82.50%	81.39%	92.95%	86.96%	87.76%	82.51%	86.55%	87.04%	90.17%
Effective Tax Rate	25.46%	26.63%	27.70%	26.43%	19.67%	27.56%	21.36%	26.37%	26.78%	25.81%
Return on Invested Capital (ROIC)	8.17%	9.82%	9.83%	11.04%	11.75%	10.91%	10.41%	10.47%	11.16%	11.30%
ROIC Less NNEP Spread (ROIC-NNEP)	7.43%	9.45%	8.48%	18.30%	10.57%	10.36%	8.90%	9.53%	9.86%	10.67%
Return on Net Nonoperating Assets (RNNOA)	5.30%	4.98%	4.39%	9.83%	5.65%	5.49%	4.01%	4.48%	4.49%	5.35%
Return on Equity (ROE)	13.47%	14.80%	14.22%	20.87%	17.40%	16.41%	14.43%	14.95%	15.65%	16.65%
Cash Return on Invested Capital (CROIC)	4.83%	-11.45%	29.05%	11.90%	11.85%	11.63%	-13.50%	8.98%	14.32%	13.10%
Operating Return on Assets (OROA)	8.30%	10.21%	8.83%	20.51%	9.82%	10.87%	8.37%	9.34%	9.46%	10.05%
Return on Assets (ROA)	4.99%	6.18%	5.20%	14.03%	6.86%	6.91%	5.43%	5.95%	6.03%	6.72%
Return on Common Equity (ROCE)	13.47%	14.80%	14.22%	20.87%	17.40%	16.41%	14.43%	14.95%	15.65%	16.65%
Return on Equity Simple (ROE_SIMPLE)	13.35%	0.00%	11.81%	16.26%	17.88%	0.00%	19.08%	14.97%	14.64%	0.00%
Net Operating Profit after Tax (NOPAT)	45	50	48	61	65	61	54	59	62	65
NOPAT Margin	4.43%	4.87%	4.74%	5.67%	5.96%	5.45%	4.74%	4.84%	4.87%	4.80%
Net Nonoperating Expense Percent (NNEP)	0.74%	0.37%	1.35%	-7.26%	1.19%	0.55%	1.52%	0.94%	1.29%	0.63%
Return On Investment Capital (ROIC_SIMPLE)	-	2.04%	-	-	-	2.47%	-	-	-	2.57%
Cost of Revenue to Revenue	78.65%	77.50%	77.46%	76.54%	76.74%	78.02%	79.19%	79.68%	79.92%	80.07%
SG&A Expenses to Revenue	13.91%	14.44%	14.56%	14.36%	14.48%	13.14%	13.50%	12.53%	12.28%	12.23%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.41%	15.86%	15.98%	15.76%	15.85%	14.46%	14.79%	13.75%	13.43%	13.47%
Earnings before Interest and Taxes (EBIT)	65	79	67	167	81	90	69	83	85	90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	82	95	83	184	97	107	85	100	101	109
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.28	3.95	4.28	3.96	4.04	4.20	4.16	3.41	3.75	2.81
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.49	1.39	1.43	1.41	1.38	1.39	1.34	1.05	1.12	0.79
Price to Earnings (P/E)	29.75	31.79	36.25	24.82	23.89	22.87	21.79	22.78	26.41	18.99
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.36%	3.15%	2.76%	4.03%	4.19%	4.37%	4.59%	4.39%	3.79%	5.27%
Enterprise Value to Invested Capital (EV/IC)	3.04	2.90	3.72	3.08	3.07	3.12	2.99	2.59	2.91	2.21
Enterprise Value to Revenue (EV/Rev)	1.70	1.58	1.62	1.56	1.54	1.55	1.53	1.21	1.25	0.93
Enterprise Value to EBITDA (EV/EBITDA)	21.36	19.26	19.38	14.54	14.13	14.19	14.32	14.25	15.22	11.77
Enterprise Value to EBIT (EV/EBIT)	27.71	24.54	24.35	17.14	16.53	16.53	16.67	17.19	18.31	14.23
Enterprise Value to NOPAT (EV/NOPAT)	29.55	35.52	35.26	31.65	29.15	28.55	28.37	23.16	25.24	19.33
Enterprise Value to Operating Cash Flow (EV/OCF)	22.57	23.34	20.17	16.58	17.86	18.01	31.88	23.23	17.68	14.37
Enterprise Value to Free Cash Flow (EV/FCFF)	64.78	0.00	11.55	25.59	25.71	26.76	0.00	29.11	20.02	16.71
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.80	0.77	0.79	0.72	0.74	0.75	0.74	0.79	0.78	0.79
Long-Term Debt to Equity	0.79	0.76	0.78	0.72	0.73	0.74	0.74	0.78	0.77	0.79
Financial Leverage	0.71	0.53	0.52	0.54	0.53	0.53	0.45	0.47	0.46	0.50
Leverage Ratio	2.41	2.30	2.34	2.28	2.27	2.25	2.30	2.31	2.33	2.35
Compound Leverage Factor	1.94	1.90	1.90	2.12	1.98	1.98	1.89	2.00	2.03	2.12
Debt to Total Capital	44.32%	43.43%	44.07%	41.89%	42.47%	42.77%	42.64%	44.07%	43.80%	44.17%
Short-Term Debt to Total Capital	0.25%	0.24%	0.25%	0.24%	0.24%	0.24%	0.24%	0.26%	0.26%	0.26%
Long-Term Debt to Total Capital	44.07%	43.19%	43.82%	41.65%	42.23%	42.53%	42.40%	43.81%	43.55%	43.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	55.68%	56.57%	55.93%	58.11%	57.53%	57.23%	57.36%	55.93%	56.20%	55.83%
Debt to EBITDA	3.48	3.28	3.15	2.39	2.31	2.26	2.24	2.85	2.83	2.81
Net Debt to EBITDA	2.65	2.38	2.27	1.40	1.47	1.53	1.78	1.89	1.60	1.77
Long-Term Debt to EBITDA	3.46	3.26	3.13	2.38	2.30	2.24	2.23	2.84	2.81	2.80
Debt to NOPAT	4.82	6.05	5.73	5.21	4.77	4.54	4.44	4.64	4.69	4.62
Net Debt to NOPAT	3.66	4.38	4.13	3.05	3.04	3.07	3.52	3.07	2.65	2.91
Long-Term Debt to NOPAT	4.79	6.02	5.70	5.18	4.74	4.51	4.42	4.61	4.66	4.60
Altman Z-Score	3.51	3.50	3.57	3.65	3.67	3.80	3.79	3.37	3.52	3.19
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.62	1.76	1.66	1.79	1.79	1.77	1.77	1.77	1.73	1.70
Quick Ratio	1.06	1.19	1.12	1.25	1.23	1.17	1.25	1.22	1.19	1.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-75	-350	429	109	95	77	-457	10	124	102
Operating Cash Flow to CapEx	1,234.95%	238.15%	1,558.19%	2,175.21%	724.31%	256.32%	-1,181.86%	2,001.18%	1,658.90%	349.34%
Free Cash Flow to Firm to Interest Expense	-5.36	-23.63	31.03	8.26	8.06	6.19	-34.62	0.82	10.05	9.40
Operating Cash Flow to Interest Expense	6.23	2.94	6.49	12.85	5.18	4.10	-5.21	15.52	12.99	3.32
Operating Cash Flow Less CapEx to Interest Expense	5.72	1.70	6.07	12.26	4.46	2.50	-5.65	14.75	12.21	2.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.31	1.34	1.35	1.31	1.33	1.36	1.39	1.38	1.43	1.51
Accounts Receivable Turnover	10.68	11.02	10.62	10.89	11.26	11.39	9.15	10.62	11.77	12.70
Inventory Turnover	14.07	15.11	13.49	12.95	13.30	13.33	14.00	13.23	13.47	12.04
Fixed Asset Turnover	37.86	35.88	37.69	38.99	41.17	37.58	39.13	39.80	40.84	40.31
Accounts Payable Turnover	8.23	9.35	7.83	7.56	7.72	8.25	7.37	7.18	7.41	7.68
Days Sales Outstanding (DSO)	34.17	33.12	34.36	33.53	32.43	32.03	39.89	34.38	31.02	28.75
Days Inventory Outstanding (DIO)	25.93	24.16	27.05	28.18	27.45	27.38	26.07	27.58	27.10	30.32
Days Payable Outstanding (DPO)	44.35	39.02	46.64	48.31	47.27	44.25	49.56	50.84	49.26	47.50
Cash Conversion Cycle (CCC)	15.75	18.25	14.76	13.39	12.60	15.17	16.40	11.12	8.86	11.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,146	2,156	1,761	2,098	2,117	2,140	2,272	2,147	2,055	2,103
Invested Capital Turnover	1.84	2.02	2.07	1.95	1.97	2.00	2.20	2.16	2.29	2.36
Increase / (Decrease) in Invested Capital	120	400	-381	-48	-30	-16	511	49	-62	-38
Enterprise Value (EV)	6,532	6,243	6,547	6,463	6,496	6,686	6,784	5,550	5,982	4,647
Market Capitalization	5,723	5,473	5,781	5,841	5,819	5,968	5,941	4,815	5,353	3,948
Book Value per Share	$7.35	$7.62	$7.42	$8.21	$8.01	$8.03	$8.22	$8.12	$8.34	$8.25
Tangible Book Value per Share	($1.20)	($0.93)	($1.01)	($0.48)	($2.47)	($0.78)	($2.52)	($2.57)	($2.48)	($2.57)
Total Capital	2,402	2,450	2,414	2,539	2,503	2,484	2,491	2,524	2,538	2,515
Total Debt	1,065	1,064	1,064	1,063	1,063	1,063	1,062	1,112	1,112	1,111
Total Long-Term Debt	1,059	1,058	1,058	1,057	1,057	1,057	1,056	1,106	1,105	1,105
Net Debt	809	770	766	622	677	719	843	735	629	699
Capital Expenditures (CapEx)	7.06	18	5.76	7.79	8.43	20	5.82	9.78	9.67	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	116	141	119	95	112	138	279	162	82	136
Debt-free Net Working Capital (DFNWC)	371	435	417	536	498	482	499	539	565	549
Net Working Capital (NWC)	365	429	411	530	492	476	493	532	558	542
Net Nonoperating Expense (NNE)	6.44	2.50	8.96	-54	8.81	4.08	9.50	6.36	8.45	4.44
Net Nonoperating Obligations (NNO)	809	770	410	622	677	719	843	735	629	699
Total Depreciation and Amortization (D&A)	18	17	16	17	17	17	16	17	16	19
Debt-free, Cash-free Net Working Capital to Revenue	3.01%	3.57%	2.95%	2.29%	2.66%	3.21%	6.30%	3.52%	1.71%	2.73%
Debt-free Net Working Capital to Revenue	9.65%	11.03%	10.31%	12.96%	11.85%	11.20%	11.25%	11.73%	11.82%	10.98%
Net Working Capital to Revenue	9.50%	10.88%	10.16%	12.82%	11.70%	11.06%	11.12%	11.59%	11.69%	10.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.21	$0.26	$0.22	$0.64	$0.31	$0.32	$0.26	$0.31	$0.32	$0.34
Adjusted Weighted Average Basic Shares Outstanding	181.88M	181.11M	181.26M	179.81M	178.83M	178.97M	173.93M	172.93M	170.64M	171.57M
Adjusted Diluted Earnings per Share	$0.21	$0.26	$0.21	$0.63	$0.31	$0.33	$0.26	$0.30	$0.31	$0.36
Adjusted Weighted Average Diluted Shares Outstanding	183.02M	182.08M	182.74M	181.24M	180.53M	180.38M	175.62M	174.09M	171.94M	172.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	181.90M	181.96M	179.76M	179.88M	177.13M	173.50M	173.82M	171.02M	170.18M	165.32M
Normalized Net Operating Profit after Tax (NOPAT)	45	50	48	61	65	61	54	59	62	65
Normalized NOPAT Margin	4.43%	4.87%	4.74%	5.67%	5.96%	5.45%	4.74%	4.84%	4.87%	4.80%
Pre Tax Income Margin	5.10%	6.31%	5.34%	14.55%	6.41%	7.02%	4.97%	5.87%	5.75%	6.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.62	5.31	4.82	12.68	6.84	7.23	5.23	6.60	6.85	8.26
NOPAT to Interest Expense	3.23	3.38	3.48	4.59	5.52	4.93	4.11	4.71	5.05	5.94
EBIT Less CapEx to Interest Expense	4.11	4.07	4.40	12.09	6.12	5.63	4.79	5.83	6.06	7.31
NOPAT Less CapEx to Interest Expense	2.73	2.15	3.07	4.00	4.81	3.33	3.67	3.94	4.26	4.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	47.03%	31.25%	68.02%	93.70%	78.96%	138.84%	112.64%	119.31%

Frequently Asked Questions About Option Care Health's Financials

When does Option Care Health's fiscal year end?

According to the most recent income statement we have on file, Option Care Health's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Option Care Health's net income changed over the last 9 years?

Option Care Health's net income appears to be on an upward trend, with a most recent value of $211.82 million in 2024, falling from -$300.13 million in 2015. The previous period was $267.09 million in 2023.

What is Option Care Health's operating income?

Option Care Health's total operating income in 2024 was $321.83 million, based on the following breakdown:

Total Gross Profit: $1.01 billion
Total Operating Expenses: $691.16 million

How has Option Care Health revenue changed over the last 9 years?

Over the last 9 years, Option Care Health's total revenue changed from $982.22 million in 2015 to $5.00 billion in 2024, a change of 408.9%.

How much debt does Option Care Health have?

Option Care Health's total liabilities were at $2.02 billion at the end of 2024, a 12.4% increase from 2023, and a 267.8% increase since 2015.

How much cash does Option Care Health have?

In the past 9 years, Option Care Health's cash and equivalents has ranged from $9.57 million in 2016 to $412.57 million in 2024, and is currently $412.57 million as of their latest financial filing in 2024.

How has Option Care Health's book value per share changed over the last 9 years?

Over the last 9 years, Option Care Health's book value per share changed from -1.18 in 2015 to 8.25 in 2024, a change of -801.4%.

Remove Ads

Related Companies

This page (NASDAQ:OPCH) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Option Care Health (OPCH) Financials

Frequently Asked Questions About Option Care Health's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Option Care Health (OPCH) Financials

Annual Income Statements for Option Care Health

Quarterly Income Statements for Option Care Health

Annual Cash Flow Statements for Option Care Health

Quarterly Cash Flow Statements for Option Care Health

Annual Balance Sheets for Option Care Health

Quarterly Balance Sheets for Option Care Health

Annual Metrics and Ratios for Option Care Health

Quarterly Metrics and Ratios for Option Care Health

Frequently Asked Questions About Option Care Health's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools